FROM MSCI ESG RESEARCH LLC.

Slides:



Advertisements
Similar presentations
Sovereign Credit Quality after the Crisis MARCH, 2010 Steve Hess, VP – Senior Credit Officer.
Advertisements

© 2013 Sri U-Thong Limited. All rights reserved. This presentation has been prepared by Sri U-Thong Limited and its holding company (collectively, “Sri.
ML Strategic Balanced Index™
Irish recovery? Pär Magnusson
Paul Bouchey, Director of Research, Parametric Portfolio Associates
WisdomTree LargeCap Dividend Fund Performance Attribution
WisdomTree LargeCap Dividend Fund Performance Attribution September 2012.
Innovations in Structured Products October 25, 2010 An Innovator’s Dilemma?
1 ©2014 MSCI Inc. All rights reserved. msci.com msci.com Systematic Equity Strategies as Sources of Risk Stanislav Radchenko April 2014.
Saxo Bank OUTLOOK 2011 Saxo Bank’s HQ in Copenhagen June 24, 2015.
2014 User Group Meeting Our commitment. Your success. Melbourne 23 October.
ETFs in Canada October 24, Disclaimer This document is for information purposes only and is not an invitation to purchase securities listed on.
TM. Step 1 Selecting your Benchmark Asset Allocation Step 1 Selecting your Benchmark Asset Allocation.
WisdomTree Emerging Markets Funds Performance Attribution December 2013.
Education’s Value Proposition MARK ZANDI, CHIEF ECONOMIST FROM MOODY’S ECONOMY.COM.
Mark Clacy-Jones, Head of Applied Research, Real Estate, MSCI
MSCI branded products include the MSCI Global Equity Indices and the MSCI ESG Indices and Research products. Widely used by institutional investors to.
An Equity Perspective Paul Malan Global Markets 21 January 2004.
Managing HFAs’ Financial Health in the Face of Uncertainty NCSHA Annual Conference October 21, 2014 Ping Hsieh, Vice President – Senior Analyst.
A Simulation approach ERES 2015, 26th June 2015
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2010 Standard.
Portfolio of Risk Premia: A New Approach to Diversification
PRODUCTIVITY – THE PICTURE FOR THE UK & THE WEST MIDLANDS SUSTAINING COMPETITIVENESS CONFERENCE – THE BELFRY RHYS HERBERT SENIOR ECONOMIST 6 JULY 2012.
WisdomTree Emerging Markets Funds Performance Attribution March 2012.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2014 by Standard.
Proportion of biotech-derived active substances in development for first launch 31st December APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2012 by Standard.
© 2015 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. CAPTURING FACTOR PREMIA RAINA OBEROI VICE PRESIDENT –
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2011 Standard.
2009 Coal Seam Gas Safety Forum Paul Zealand, Executive General Manager Upstream Oil & Gas Friday 14 August 2009.
Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.
WisdomTree Emerging Markets Funds Performance Attribution June 2011.
2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
WisdomTree LargeCap Dividend Fund Performance Attribution March 2012.
Investec Asset Management Update on Asset Class Returns December 2015.
© 2016 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. FINANCIAL PERFORMANCE MEASUREMENT IN SOCIAL HOUSING February.
Notes on Equal Weighted Indices Fei Mei Chan Craig J. Lazzara, CFA S&P Indices June 19, 2012.
Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
© 2015 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. MSCI ALL CHINA INDEX Proposed treatment of foreign listed.
Permission to reprint or distribute any content from this presentation requires the prior written approval of S&P Global Ratings. Copyright © 2016 by Standard.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2011 Standard.
The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.
ETF Forum Marketplace – Toronto Stock Exchange June 2011 Gary Knight Vice President, Trading.
WisdomTree LargeCap Dividend Fund Performance Attribution December 2011.
Aberdeen’s Stewardship Capabilities
Vietnam Market Classification
amaranth DMS UCITS PLATFORM ICAV P/E FX Strategy Fund
BIOLOGY / CHEMISTRY CITATIONS GROWTH
Real Estate Performance and Risk: The Importance of Perspective
Selecting the right provider
Under-rated assets in an over-priced world
Consultation on implementation of 2018 GICS changes in THE MSCI EQUITY INDEXES March 2018 This consultation may or may not lead to the implementation of.
Time Targeted Portfolios
IA Clarington Inhance SRI Funds
Self-Registration walk-through
2006 Revenue continued to depend on a relatively small number of products APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
, R&D expenditure showed 6% growth annually
Timeline of Major Political and Economic Events
Proportion of total R&D expenditure on alliances or joint ventures by stage of R&D in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
% of the projects in development in the leading therapeutic areas were considered to have a novel mode of action APRIL 2007 SOURCE: CMR INTERNATIONAL.
Cambria Armor Dividend Strategy Cambria Armor Growth Strategy
Environmental Upgrade Finance
Cycle times decreased in larger but not smaller, companies
Unique data, real insight
Index Announcement New York, NY, November 16, 2018 – The Return on Disability Group announces changes to its Return on Disability US LargeCap ETN Total.
2011 U.S. Proxy Season Review and 2012 Preview
TITLE Source: Footnotes:. TITLE Source: Footnotes:
© 2013 Sri U-Thong Limited. All rights reserved
Emotional Intelligence: The Core of Family Offices
RHO Index Key Levels 13 June 2019.
Presentation transcript:

FROM MSCI ESG RESEARCH LLC. Linda-Eling Lee 2017年7月

MSCI 服务全球ESG投资 47of 50 155+ 1000+ 700+ ESG analysts1 (250+ staff) clients Paris London Frankfurt Geneva Beijing Hong Kong Manila Sydney Cape Town Mumbai San Francisco Boston New York Gaithersburg Monterrey Toronto Portland Tokyo Stockholm Chicago 47of 50 Global asset managers2 TOP 700+ ESG equity & fixed income indexes 1 Source: MSCI ESG Research as of June 2016 2 Based on P&I AUM data as of Dec 2015 and MSCI clients as of June 2016 MSCI ESG Research awarded First Place in 13 out of 17 categories, including: Best firm for Socially Responsible Investing Research Corporate Governance Research | Indexes | Data Fixed Income Research | Emerging Markets Research

为不同类型的ESG投资策略提供研究和数据支持 We rate 6,200 companies (11,000 total issuers including subsidiaries) and more than 350,000 equity and fixed income securities globally ESG METRICS SUSTAINABLE IMPACT METRICS ESG RATINGS BUSINESS INVOLVEMENT SCREENING NORMS & CONTROVERSIES GOVERNANCE METRICS ENVIRONMENTAL & SOCIAL METRICS OUTPUT MSCI ESG RESEARCH CARBON METRICS IMPACT METRICS CLEAN TECH METRICS SOCIAL METRICS ESG INTEGRATION SCREENING - VALUES ALIGNMENT IMPACT INVESTING ACCOUNTING METRICS  Company, industry, and thematic reports  Portfolio analytics  Data feeds ESG RATINGS: Equity : 6,200 Issuers Fixed Income: 350,000 Securities Funds and ETFs: 23,000 GLOBAL SANCTIONS INVOLVEMENT SCREENS CARBON SCREENING CONTROVERSIES GLOBAL NORMS BUSINESS INVOLVEMENT: Equities: All publicly traded companies Fixed Income: Over 500,000 Securities NORMS & CONTROVERSIES: Equities: ACWI IMI (9,000 Issuers) Fixed Income: Over 300,000 Securities CLEAN TECH METRICS: Equity: MSCI ACWI IMI SOCIAL METRICS: Equity: MSCI ACWI We offer a comprehensive range of ESG data and tools designed to support a variety of ESG investment approaches, from values based investing, to impact investing and integration, but here we are focusing on our ESG Ratings which are specifically designed to support the integration of ESG factors into the investment process.

MSCi ESG 指数系列 MSCI offers a comprehensive range of ESG indexes for ESG investors pursuing different objectives 4

全球ESG投资快速增长 Gathering Momentum Assets Benchmarked to MSCI ESG Indexes2 Over 1,500 firms have committed to ESG integration as signatories to the UNPRI, including more than 300 asset owners Over USD 56 Billion in assets are benchmarked to MSCI ESG Indexes2 USD Billion ETF 3.98 Passive 51.76 Active 1.04 Total 56.78 Growth of AUM and Number of ETFs tracking MSCI ESG Indexes3 Dedicated low carbon investments by the world’s 500 biggest investors grew 63% from 2015 to $138B1 1 BlackRock , Exploring ESG: A Practitioner’s Perspective 2 as of Dec 2016, based on Bloomberg, Morningstar and MSCI data. Active AUM includes data as of September 30, 2016 reported on December 31, 2016 by eVestment. 3as of Dec 31, 2016, based on data from Bloomberg 5

Price Performance in USD 为什么ESG投资会快速增长? Price Performance in USD MSCI World MSCI Emerging Markets (May 2011- December 2016) 6

Notice and disclaimer This document and all of the information contained in it, including without limitation all text, data, graphs, charts (collectively, the “Information”) is the property of MSCI Inc. or its subsidiaries (collectively, “MSCI”), or MSCI’s licensors, direct or indirect suppliers or any third party involved in making or compiling any Information (collectively, with MSCI, the “Information Providers”) and is provided for informational purposes only. The Information may not be modified, reverse-engineered, reproduced or redisseminated in whole or in part without prior written permission from MSCI. The Information may not be used to create derivative works or to verify or correct other data or information. For example (but without limitation), the Information may not be used to create indexes, databases, risk models, analytics, software, or in connection with the issuing, offering, sponsoring, managing or marketing of any securities, portfolios, financial products or other investment vehicles utilizing or based on, linked to, tracking or otherwise derived from the Information or any other MSCI data, information, products or services. The user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. NONE OF THE INFORMATION PROVIDERS MAKES ANY EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE USE THEREOF), AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EACH INFORMATION PROVIDER EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES (INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF ORIGINALITY, ACCURACY, TIMELINESS, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE INFORMATION. Without limiting any of the foregoing and to the maximum extent permitted by applicable law, in no event shall any Information Provider have any liability regarding any of the Information for any direct, indirect, special, punitive, consequential (including lost profits) or any other damages even if notified of the possibility of such damages. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited, including without limitation (as applicable), any liability for death or personal injury to the extent that such injury results from the negligence or willful default of itself, its servants, agents or sub-contractors. Information containing any historical information, data or analysis should not be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. Past performance does not guarantee future results. The Information should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. All Information is impersonal and not tailored to the needs of any person, entity or group of persons. None of the Information constitutes an offer to sell (or a solicitation of an offer to buy), any security, financial product or other investment vehicle or any trading strategy. It is not possible to invest directly in an index. Exposure to an asset class or trading strategy or other category represented by an index is only available through third party investable instruments (if any) based on that index. MSCI does not issue, sponsor, endorse, market, offer, review or otherwise express any opinion regarding any fund, ETF, derivative or other security, investment, financial product or trading strategy that is based on, linked to or seeks to provide an investment return related to the performance of any MSCI index (collectively, “Index Linked Investments”). MSCI makes no assurance that any Index Linked Investments will accurately track index performance or provide positive investment returns. MSCI Inc. is not an investment adviser or fiduciary and MSCI makes no representation regarding the advisability of investing in any Index Linked Investments. Index returns do not represent the results of actual trading of investible assets/securities. MSCI maintains and calculates indexes, but does not manage actual assets. Index returns do not reflect payment of any sales charges or fees an investor may pay to purchase the securities underlying the index or Index Linked Investments. The imposition of these fees and charges would cause the performance of an Index Linked Investment to be different than the MSCI index performance. The Information may contain back tested data. Back-tested performance is not actual performance, but is hypothetical. There are frequently material differences between back tested performance results and actual results subsequently achieved by any investment strategy. Constituents of MSCI equity indexes are listed companies, which are included in or excluded from the indexes according to the application of the relevant index methodologies. Accordingly, constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI. Inclusion of a security within an MSCI index is not a recommendation by MSCI to buy, sell, or hold such security, nor is it considered to be investment advice. Data and information produced by various affiliates of MSCI Inc., including MSCI ESG Research Inc. and Barra LLC, may be used in calculating certain MSCI indexes. More information can be found in the relevant index methodologies on www.msci.com. MSCI receives compensation in connection with licensing its indexes to third parties. MSCI Inc.’s revenue includes fees based on assets in Index Linked Investments. Information can be found in MSCI Inc.’s company filings on the Investor Relations section of www.msci.com. MSCI ESG Research Inc. is a Registered Investment Adviser under the Investment Advisers Act of 1940 and a subsidiary of MSCI Inc. Except with respect to any applicable products or services from MSCI ESG Research, neither MSCI nor any of its products or services recommends, endorses, approves or otherwise expresses any opinion regarding any issuer, securities, financial products or instruments or trading strategies and MSCI’s products or services are not intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Issuers mentioned or included in any MSCI ESG Research materials may include MSCI Inc., clients of MSCI or suppliers to MSCI, and may also purchase research or other products or services from MSCI ESG Research. MSCI ESG Research materials, including materials utilized in any MSCI ESG Indexes or other products, have not been submitted to, nor received approval from, the United States Securities and Exchange Commission or any other regulatory body. Any use of or access to products, services or information of MSCI requires a license from MSCI. MSCI, Barra, RiskMetrics, IPD, FEA, InvestorForce, and other MSCI brands and product names are the trademarks, service marks, or registered trademarks of MSCI or its subsidiaries in the United States and other jurisdictions. The Global Industry Classification Standard (GICS) was developed by and is the exclusive property of MSCI and Standard & Poor’s. “Global Industry Classification Standard (GICS)” is a service mark of MSCI and Standard & Poor’s.